secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2021-08-19T23:59:59+00:00
Accession:  0001140361-21-028904
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Kevin B. Churchwell resigns from Cyclerion board effective Aug 18, 2021
--------------------------------------------------------------------------------

- Kevin B. Churchwell, M.D. resigned from the board of directors on August 18, 2021.
- No disagreement with company operations, policies, or practices cited.
- Resignation due to expanded responsibilities as CEO of Boston Children's Hospital.
- Marsha Fanucci, Board Chair, thanked Churchwell for his service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000114036121028904/0001140361-21-028904-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000114036121028904/brhc10028200_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-21-028904

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer